The Company is a supplier of products that process, store and administer therapeutic doses of adult stem cells for treatment of disease and injury.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
A moderately conservative way to play the risky stem cell sector. Projected for positve EPS in next year and would be low PE if hits estimate.